A report of two cases of Kawasaki disease treated with plasma exchange

Therapeutic Apheresis and Dialysis

Volumn 12, Issue 2, 2008, Pages 176-179

  Harada, Tomonori ^a   Ito, Shuichi ^a   Shiga, Kentaro ^a   Inaba, Aya ^a   Machida, Hiroyuki ^a   Aihara, Yukoh ^a   Yokota, Shumpei ^a  

^a YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

Author keywords

Acute heart failure; Coronary artery lesions; Kawasaki disease; Plasma exchange; Shock

Indexed keywords

ACETYLSALICYLIC ACID; CATECHOLAMINE; DOBUTAMINE; DOPAMINE; IMMUNOGLOBULIN; NORADRENALIN;

ACUTE HEART FAILURE; ARTICLE; ARTIFICIAL VENTILATION; CARDIOGENIC SHOCK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; CARDIOVASCULAR RISK; CASE REPORT; CLINICAL FEATURE; CONSCIOUSNESS DISORDER; CORONARY ARTERY; CORONARY ARTERY DISEASE; DRUG MEGADOSE; EARLY INTERVENTION; FEMALE; FEVER; HEART FAILURE; HUMAN; INCIDENCE; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PLASMAPHERESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY FAILURE; TREATMENT RESPONSE; VASCULITIS;

CHILD, PRESCHOOL; CORONARY VESSELS; FEMALE; HEART FAILURE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PLASMA EXCHANGE; TREATMENT OUTCOME;

EID: 41749083490     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2008.00566.x     Document Type: Article

References (21)

1. Kawasaki T. Acute febrile mucocutaneus syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Clinical observation of 50 cases. Jpn J Allergy 1967 16 : 178 222.
2. Fukunishi M, Kikkawa M, Hamana K et al. Prediction of non-responsiveness to intravenous high-dose γ-globulin therapy in patients with Kawasaki disease at onset. J Pediatr 2000 137 : 172 6.
3. Imagawa T, Mori M, Miyamae T et al. Plasma exchange for refractory Kawasaki disease. Eur J Pediatr 2004 163 : 263 4.
4. Matsubara T, Furukawa S, Yabuta K. Serum levels of tumor necrosis factor, interleukin-2 receptor, and interferon-γ, in Kawasaki disease involved coronary lesions. Clin Immunol Immunopathol 1990 56 : 29 36.
5. Okada Y, Shinohara M, Kobayashi T et al. Effect of corticosteroids in addition to intravenous gamma globulin therapy on serum cytokine levels in the acute phase of Kawasaki disease in children. J Pediatr 2003 143 : 363 7.
6. Sohn MH, Noh SY, Chang W, Shin KM, Kim DS. Circulating interleukin 17 is increased in the acute stage of Kawasaki disease. Scand J Rheumatol 2003 32 : 364 6.
7. Hui-Yuen JS, Duong TT, Yeung RS. TNF-α is necessary for induction of coronary artery inflammation and aneurysm formation in an animal model of Kawasaki disease. J Immunol 2006 176 : 6294 301.
8. Shumak KH, Rock GA. Theraputic plasma exchange. N Engl J Med 1984 310 : 762 71.
9. Heard SO, Perkins MW, Fink MP. Tumor necrosis factor-α causes myocardial depression in guinea pigs. Crit Care Med 1992 20 : 523 7.
10. Ren J, Relling DP. Interaction between tumor necrosis factor-α and leptin-induced inhibition of cardiac contractile function in isolated ventricular myocytes. Cytokine 2005 32 : 213 18.
11. Janssen SP, Gayan-Ramirez G, Van den Bergh A et al. Interleukin-6 causes myocardial failure and skeletal muscle atrophy in rats. Circulation 2005 111 : 996 1005.
12. Kumar A, Thota V, Dee L, Olson J, Uretz E, Parrillo JE. Tumor necrosis α and interleukin 1β are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med 1996 183 : 949 58.
13. Ohno T, Yuge T, Kariyazono H et al. Serum hepatocyte growth factor combined with vascular endothelial growth factor as a predictive indicator for the occurrence of coronary artery lesions in Kawasaki disease. Eur J Pediatr 2002 161 : 105 11.
14. Suzuki A, Miyagawa-Tomita S, Komatsu K et al. Immunohistochemical study of apparently intact coronary artery in a child after Kawasaki disease. Pediatr Int 2004 46 : 590 6.
15. Bellomo R. The cytokine network in the critically ill. Anaesth Intensive Care 1992 20 : 288 302.
16. Pickkers P, Sprong T, Eijk L, Hoeven H, Smits P, Deuren M. Vascular endothelial growth factor is increased during the first 48 hours of human septic shock and correlates with vascular permeability. Shock 2005 24 : 508 12.
17. Habersetzer R, Samtleben W, Blumenstein M, Gurland HJ. Plasma exchange in systemic lupus erythematosus. Int J Artif Organs 1983 6 : 39 41.
18. Webb JG, Butany J, Langer G, Scott G, Liu PP. Myocarditis and myocardial hemorrhage associated with thrombotic thrombocytopenic purpura. Arch Intern Med 1990 150 : 1535 7.
19. Dornan RI. Acute postoperative biventricular failure associated with antiphospholipid antibody syndrome. Br J Anaesth 2004 92 : 748 54.
20. Yosikawa M, Okuno T, Mikawa H. Prognosis and treatment of polymyositis with particular reference to steroid resistant patients. Arch Dis Child 1985 60 : 236 44.
21. Tabbutt S, Leonard M, Godinez RI et al. Severe influenza B myocarditis and myositis. Pediatr Crit Care Med 2004 5 : 403 6.